In the new COVID test, it is the binding of the SARS-CoV-2 spike protein to a metallic substrate that triggers the ...

"The Lateral Flow Assays Market Size was US$ 7.51 billion in 2024, with a rise of US$ 7.50 billion in 2024, and is expected ...

Clinical testing remained the leading application segment in 2024. The lateral flow assays market is expected to reach ...

The global Lateral Flow Assay Components Market, valued at US$378.4 million in 2024, stood at US$392.4 million in 2025 and is ...

AUSTIN, Texas and TOKYO, Sept. 9, 2025 /PRNewswire/ -- "The Lateral Flow Assays Market Size was US$ 7.51 billion in 2024, with a rise of US$ 7.50 billion in 2024, and is expected ...

You can exhibit COVID-19 symptoms yet test negative due to early infection, low viral load, or immune response. PCR testing ...

The Canadian company is also working to increase utilization of its point-of-care infectious disease assays, such as tests for HIV and syphilis.

The findings provide evidence of SARS-CoV-2 spillover from people to pet dogs and underscore the importance of continued ...

Today, the majority of people who catch Covid will have very similar symptoms to other illnesses, such as colds and flu. Most people feel better within a few weeks, but it can take longer to recover.

IPO candidate Nexsen hopes to revolutionise the market for real-time diagnostic testing, whilst eyeing fast-track FDA ...

New COVID-19 variant XFG has firmly positioned itself as the predominant strain in the United States as cases continue to crop up nationwide. Some regions of the U.S. are experiencing higher rates of ...

The global antibody testing market is projected to grow at a CAGR of 6% from 2025 to 2030, driven by the rising prevalence of ...